-
Publication Year2024
Our Research
- Prostate/Bladder Cancer Biobank and Clinical Database
- Clinical Trials in NMIBC and High Risk Prostate Cancer
- CRISPR Screen of Surface Targets in Bladder and Prostate
- Drug Resistance Mechanisms in vitro
- PET-based imaging in bladder and prostate cancers
Our People
Research Team and Lab Collaborators

Post-doc
Project(s)
- STEAP1 CRISPR screen (prostate)
- NECTIN4 CRISPR screen (bladder)
- Prostate cancer biomarkers

MS3 (UCSF)
Project(s)
- Staging impact of PSMA PET imaging
- ArteraAI classifier for BCG response in NMIBC

Senior Specialist
Project(s)
Resistance mechanisms to targeted therapies in vitro models
Mentors and Collaborators
Latest Research
Role of PSMA PET in Surgical Planning, Post-Operative Management
2025 PSMA and Beyond Conference
Presentation by Dr. Carissa Chu
Neoadjuvant Prostate Cancer Clinical Trials: Advancing Care and Science
BIPCR Basic Research in Prostate Cancer
Presentation by Dr. Carissa Chu
Bench to Bedside: Translational Approaches to Studying Drug Resistance in Urothelial Carcinoma
UCSF Urology Grand Rounds
Presentation by Dr. Carissa Chu
Funding
NIH K12 UCSF Physician Scientist Program in Clinical Oncology
2024-2026
Principal Investigator
Identifying biomarkers of enfortumab vedotin response in bladder cancer and defining mechanisms of resistance
Stephen and Faith Brown Endowed Professorship in Urology
Prostate Cancer Foundation (PCF) Young Investigator Award
UCSF Prostate Cancer SPORE Career Enhancement Program Awardee
Featured Work
-
Publication Year2023
-
Publication Year2022